Bing

SEARCH HISTORY

One stock that might be an intriguing choice for investors right now is. ArQule Inc. (ARQL). This is because this security in the Biotechnology industry space is seeing solid earnings estimate revision activity, and is in great company from a Zacks ...
Yahoo Finance · 12/27/2013
Explore the tool here. Article printed from InvestorPlace Media, http://investorplace.com/2015/07/7-biotechnology-stocks-to-buy-now-arql-ljpc-incy/.
Investor Place · 7/1/2015
ArQule Inc. ( ARQL) was a big mover last session with its shares rising over 19% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has ...
NASDAQ · 2/27/2015
More from Bing News
Investors in ArQule Inc. (ARQL) saw new options become available this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARQL options chain for the new May 15th contracts and identified the ...
The Street · 3/25/2015
ArQule (NASDAQ:ARQL) traded up 3.85% on Friday, hitting $1.62. The stock had a trading volume of 190,114 shares. ArQule has a 52 week low of $1.04 and a 52 week high of $2.50. The stock has a 50-day moving average of $1.77 and a 200-day moving …
Ticker Report · 7/3/2015
Active Power (NASDAQ:ACPW): Ascolese Mark A bought 8,631 stocks at $1.87. Agilysys (NASDAQ:AGYS): Kolerus Keith M bought 9,196 stocks at $12.02. Arqule (NASDAQ:ARQL): Zenner Patrick J bought 20,830 stocks at $1.20. American Science …
Fx Pips · 11/18/2014
ArQule (NASDAQ:ARQL) stock fell 23 percent on Wednesday on safety concerns about its drug candidate tivantinib. Wednesday, shares were trading at $5.15, down 9 per cent from the start of the year. Tivantinib is a treatment for lung cancer. In a federal ...
Proactiveinvestors · 8/29/2012
Keep a close eye on ARQL. The company provided positive clinical updates on the ongoing pivotal Phase 3 METIV-HCC trial in hepatocellular carcinoma (liver cancer), and on the completed amended Phase 3 ATTENTION trial in non-squamous non-small …
Smallcap Network · 1/17/2014
Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >> Get the latest research report on ARQL - FREE Get the latest research report on ACRX - FREE Get the latest research report on ADHD - FREE
ZACKS · 11/11/2014
Is ArQule, Inc. (NASDAQ:ARQL) a good investment? In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks. A duo of the most innovative are hedge fund and insider trading sentiment. At Insider Monkey ...
INSIDER MONKEY · 9/3/2013